KRAS and neoplasm: One of the miRNAs dysregulated in PC and targeting KRAS is hsa-miR-885-5p, which has previously been reported [52] as a tumour suppressor in hepatocellular carcinoma by regulating AEG1 and as an inhibitor of invasion and metastasis in gastric cancer by regulating ME1 [53].